AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportGlass Health vs OpenEvidence
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
Glass Health
VS
OpenEvidence
Verdict by Category
AI content generation failed. Refresh the page to try again.
Detailed Comparison
Feature
Glass Health
OpenEvidence
Pricing
FreemiumGlass Health publishes its pricing transparently:
Lite (Free): Basic clinical decision support and differential diagnosis with usage limits.
Starter at $20/month: Expanded ambient scribing and CDS features for regular clinical use.
Pro at $90/month: Extended ambient scribing, extended CDS, and extended Deep Reasoning for complex cases.
Max at $200/month: Maximum all features, priority response processing, and full EHR integration via SMART on FHIR (Epic, eClinicalWorks, athenahealth, Elation). Team plans available for group practices.
FreemiumOpenEvidence is free for all verified US healthcare professionals. NPI verification is required to access the platform. The free tier includes full medical AI search, DeepConsult, Visits, Voice Mode, clinical calculators, and the AI-Integrated Doctor Dialer.
Enterprise pricing applies to health system deployments with EHR integration (Epic), multi-subspecialist AI agents, custom knowledge bases, priority compute, advanced visualization, and API licensing for clinical decision support integration into third-party platforms.
Contact OpenEvidence through openevidence.com for enterprise and health system pricing. Note: The platform withdrew from the EU and UK in April 2026 and is currently available to US healthcare professionals only.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education ToolsAI Search Engines
Summary
AI clinical decision support + ambient scribing in one workflow — real-time CDS and transparent pricing
AI clinical decision support free for verified physicians — 757K+ doctors, $12B valuation, peer-reviewed answers
Glass Health Pros & Cons
Pros
- Only platform combining real-time Ambient CDS and ambient scribing in one unified clinical workflow
- Transparent published pricing (free to $200/mo) — rare in a category where most require sales conversations
- Evolving differential diagnosis during encounter — AI thinking partner not just a documentation tool
- SMART on FHIR EHR integration at Max tier — works natively inside Epic, eClinicalWorks, athenahealth, Elation
- Backed by Y Combinator, Initialized Capital, and Breyer Capital — strong early-stage pedigree
- Google for Startups AI First Accelerator alumnus (Apr 2024)
- Free Lite plan — no cost barrier for clinicians to evaluate real-time clinical AI support
Cons
- Early-stage company with ~$6.5M total funding — small vs OpenEvidence ($250M) or Doximity ($644M revenue)
- Max plan EHR integration at $200/month expensive for solo practitioners
- English-only — not suitable for multilingual clinical practices
- AI-generated differential not physician-reviewed like OpenEvidence or UpToDate content
- Less comprehensive clinical content than UpToDate’s 13,000+ expert-authored topics
- Small team (~7 employees) — limited engineering resources for product roadmap
OpenEvidence Pros & Cons
Pros
- Free for all verified US physicians — no cost barrier for individual clinician adoption
- 757,000+ verified physicians, 40%+ of US doctors use it daily — most widely adopted clinical AI in the US
- $12B valuation (January 2026), $250M Series D — Thrive Capital and DST Global backed
- Answers grounded exclusively in peer-reviewed literature — zero hallucination risk from non-medical sources
- 20M+ clinical consultations per month — proven real-world clinical usage at unprecedented scale
- Epic EHR integration live at Sutter Health — first public health system embedding of clinical AI in EHR
- DeepConsult AI agent handles multi-step clinical reasoning — goes beyond basic search to structured clinical analysis
Cons
- Withdrew from EU and UK in April 2026 — US-only availability limits international use
- Free tier requires verified NPI number — not accessible to non-US clinicians or students without credentials
- Impact on actual clinical decision-making scored only 1.95/4 in one study — physicians still cautious
- DeepConsult and enterprise features require institutional pricing
- Full chart-aware clinical support (reading patient records proactively) not yet available
- Only 20% of physicians fully support AI in clinical decision-making — adoption barriers remain